ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DPH Dechra Pharmaceuticals Plc

3,866.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3,866.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dechra Pharmaceuticals PLC Director/PDMR Shareholding (1005A)

21/03/2017 2:10pm

UK Regulatory


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 1005A

Dechra Pharmaceuticals PLC

21 March 2017

21 March 2017

Dechra Pharmaceuticals PLC

(the Company)

Director Shareholding

Dechra Pharmaceuticals PLC has been notified that on 21 March 2017 Anthony Griffin, Executive Director, sold 3,500 ordinary shares in the Company at a price of GBP16.76 each.

Following this acquisition, Anthony Griffin's beneficial interest in the Company is 64,320 shares (0.069% of the current issued share capital).

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ------------------------------------------------------------- 
 a)   Name                            Anthony Griffin 
---  ------------------------------  ----------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------- 
 a)   Position/status                 Director 
---  ------------------------------  ----------------------------- 
 b)   Initial notification/           Initial Notification 
       amendment 
---  ------------------------------  ----------------------------- 
 3.   Details of the Issuer 
---  ------------------------------------------------------------- 
 a)   Name                            Dechra Pharmaceuticals PLC 
---  ------------------------------  ----------------------------- 
 b)   LEI code                        N/A 
---  ------------------------------  ----------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------- 
 a)   Description                     Ordinary Shares of 1 pence 
       of the financial                each 
       instrument                      ISIN: GB0009633180 
       Identification 
       code 
---  ------------------------------  ----------------------------- 
 b)   Nature of                       Sale of Shares 
       the transaction 
---  ------------------------------  ----------------------------- 
 c)   Price(s) and                    Price(s)       Volume(s) 
       volumes(s) 
                                       16.76          3,500 
---  ------------------------------  -------------  -------------- 
 d)        Aggregated                  3,500 
            information                 GBP16.76 
             *    Aggregate volume      GBP58,660.00 
 
 
             *    Price 
 
 
             *    Total 
---  ------------------------------  ----------------------------- 
 e)   Date of the                     2017.03.21 
       transaction 
---  ------------------------------  ----------------------------- 
 f)   Place of the                    London Stock Exchange 
       transaction 
---  ------------------------------  ----------------------------- 
 

For further information, please contact:

Suzana Cross, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKDDKQBKDFNB

(END) Dow Jones Newswires

March 21, 2017 10:10 ET (14:10 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock